• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有 2 型糖尿病家族史的超重非糖尿病个体发生脂肪肝疾病的预测因素。

A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight.

机构信息

Unit of Geriatrics and Internal Medicine, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, 70013, Castellana Grotte, BA, Italy.

Unit of Data Sciences and Technology Innovation for Population Health, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, 70013, Castellana Grotte, BA, Italy.

出版信息

Sci Rep. 2021 Dec 16;11(1):24084. doi: 10.1038/s41598-021-03583-3.

DOI:10.1038/s41598-021-03583-3
PMID:34916558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8677812/
Abstract

Comprehensive screening for non-alcoholic fatty liver disease (NAFLD) may help prompt clinical management of fatty liver disease. A family history, especially of diabetes, has been little studied as a predictor for NAFLD. We characterized the cross-sectional relationship between a family history of type 2 diabetes (FHT2D) and NAFLD probability in 1185 diabetes-free Apulian (Southern-Italy) subjects aged > 20 years with overweight or obesity not receiving any drug or supplementation. Clinical data and routine biochemistry were analysed. NAFLD probability was defined using the fatty liver index (FLI). A first-degree FHT2D was assessed by interviewing subjects and assigning a score of 0, 1, or 2 if none, only one, or both parents were affected by type 2 diabetes mellitus (T2DM). Our study population featured most females (70.9%, N = 840), and 48.4% (N = 574) of the sample had first-degree FHT2D. After dividing the sample by a FHT2D, we found a higher BMI, Waist Circumference (WC), and diastolic blood pressure shared by FHT2D subjects; they also showed altered key markers of glucose homeostasis, higher triglyceride levels, and worse liver function. FLI scores were significantly lower in subjects without a first-degree FHT2D. After running logistic regression models, a FHT2D was significantly associated with the NAFLD probability, even adjusting for major confounders and stratifying by age (under and over 40 years of age). A FHT2D led to an almost twofold higher probability of NAFLD, regardless of confounding factors (OR 2.17, 95% CI 1.63 to 2.89). A first-degree FHT2D acts as an independent determinant of NAFLD in excess weight phenotypes, regardless of the age group (younger or older than 40 years). A NAFLD risk assessment within multidimensional screening might be useful in excess weight subjects reporting FHT2D even in the absence of diabetes.

摘要

全面筛查非酒精性脂肪性肝病 (NAFLD) 可能有助于促进脂肪性肝病的临床管理。家族史,尤其是糖尿病家族史,作为 NAFLD 的预测因子,研究甚少。我们描述了在 1185 名年龄大于 20 岁、超重或肥胖且未服用任何药物或补充剂的无糖尿病的阿普利亚(意大利南部)人群中,2 型糖尿病家族史 (FHT2D) 与 NAFLD 概率之间的横断面关系。分析了临床数据和常规生化指标。使用脂肪肝指数 (FLI) 定义 NAFLD 概率。通过访谈受试者并给与 0、1 或 2 分来评估一级 FHT2D,如果没有、仅有一位或两位父母患有 2 型糖尿病 (T2DM)。我们的研究人群以女性为主 (70.9%,N=840),样本中有 48.4% (N=574) 的人有一级 FHT2D。根据 FHT2D 对样本进行分组后,我们发现 FHT2D 受试者的 BMI、腰围 (WC) 和舒张压更高;他们的糖代谢关键标志物也发生改变,甘油三酯水平更高,肝功能更差。无一级 FHT2D 的受试者的 FLI 评分明显较低。进行逻辑回归模型后,即使在调整主要混杂因素并按年龄(40 岁以下和以上)分层后,FHT2D 仍与 NAFLD 概率显著相关。FHT2D 使 NAFLD 的发生概率增加近两倍,无论是否存在混杂因素 (OR 2.17,95%CI 1.63 至 2.89)。一级 FHT2D 是超重表型中 NAFLD 的独立决定因素,无论年龄组(40 岁以下或以上)如何。即使在没有糖尿病的情况下,超重受试者报告有 FHT2D 时,在多维筛查中进行 NAFLD 风险评估可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019a/8677812/b5782c31e3ae/41598_2021_3583_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019a/8677812/b5782c31e3ae/41598_2021_3583_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/019a/8677812/b5782c31e3ae/41598_2021_3583_Fig1_HTML.jpg

相似文献

1
A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight.有 2 型糖尿病家族史的超重非糖尿病个体发生脂肪肝疾病的预测因素。
Sci Rep. 2021 Dec 16;11(1):24084. doi: 10.1038/s41598-021-03583-3.
2
Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).脂肪肝指数可预测前驱糖尿病、2型糖尿病和非酒精性脂肪性肝病(NAFLD)的发病风险。
Ann Med. 2021 Dec;53(1):1256-1264. doi: 10.1080/07853890.2021.1956685.
3
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
4
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.甘油三酯葡萄糖指数及相关参数(甘油三酯葡萄糖-体重指数和甘油三酯葡萄糖-腰围)可识别超重/肥胖个体的非酒精性脂肪肝和肝纤维化。
Metab Syndr Relat Disord. 2021 Apr;19(3):167-173. doi: 10.1089/met.2020.0109. Epub 2020 Dec 1.
5
Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.瘦型非酒精性脂肪性肝病增加了正常体重中国人群发生代谢紊乱的风险。
World J Gastroenterol. 2014 Dec 21;20(47):17932-40. doi: 10.3748/wjg.v20.i47.17932.
6
Non-obese or lean non-alcoholic fatty liver disease was associated with increased risk of cancer in patients with type 2 diabetes mellitus.非肥胖或非消瘦的非酒精性脂肪性肝病与 2 型糖尿病患者的癌症风险增加相关。
BMJ Open Diabetes Res Care. 2023 Feb;11(1). doi: 10.1136/bmjdrc-2022-003066.
7
Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.肝脂肪变指数和脂肪肝指数与 2 型糖尿病患者颈动脉粥样硬化的关系。
Int J Med Sci. 2021 Jul 23;18(14):3280-3289. doi: 10.7150/ijms.62010. eCollection 2021.
8
Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.2型糖尿病患者非酒精性脂肪性肝病的发生时间及消退情况
Diabetes Metab Res Rev. 2017 May;33(4). doi: 10.1002/dmrr.2878. Epub 2017 Jan 27.
9
The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.在资源有限的环境中,脂肪肝指数对超重和肥胖儿童非酒精性脂肪肝的筛查准确性。
BMC Pediatr. 2022 Aug 30;22(1):511. doi: 10.1186/s12887-022-03575-w.
10
Gender-specific association between non-alcoholic fatty liver disease and type 2 diabetes mellitus among a middle-aged and elderly Chinese population: An observational study.非酒精性脂肪性肝病与中老年人群 2 型糖尿病的性别相关性:一项观察性研究。
Medicine (Baltimore). 2021 Feb 12;100(6):e24743. doi: 10.1097/MD.0000000000024743.

引用本文的文献

1
Assessment of Non-alcoholic Fatty Liver Disease and Level of Risk of Fibrosis in Diabetic and Non-diabetic Individuals.糖尿病和非糖尿病个体的非酒精性脂肪性肝病评估及纤维化风险水平
Cureus. 2024 Dec 21;16(12):e76162. doi: 10.7759/cureus.76162. eCollection 2024 Dec.
2
NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic-Metabolic Interplay.非酒精性脂肪性肝病纤维化进展与2型糖尿病:肝脏-代谢相互作用
Life (Basel). 2024 Feb 18;14(2):272. doi: 10.3390/life14020272.
3
The interaction of perfluoroalkyl acids and a family history of diabetes on arthritis: analyses of 2011-2018 NHANES.

本文引用的文献

1
Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes.非酒精性脂肪性肝病与无糖尿病受试者糖化血红蛋白水平升高呈正相关。
J Clin Med. 2021 Apr 15;10(8):1695. doi: 10.3390/jcm10081695.
2
Non-Alcoholic Fatty Liver Disease in Cuba.古巴的非酒精性脂肪性肝病。
MEDICC Rev. 2021 Jan;23(1):64-71. doi: 10.37757/MR2021.V23.N1.11. Epub 2021 Jan 30.
3
Family History of Diabetes and the Effectiveness of Lifestyle Intervention on Insulin Secretion and Insulin Resistance in Chinese Individuals with Metabolic Syndrome.
全氟烷基酸与糖尿病家族史对关节炎的交互作用:2011-2018 年 NHANES 的分析。
BMC Public Health. 2024 Feb 12;24(1):448. doi: 10.1186/s12889-024-17879-2.
4
The Effect of Lipopolysaccharide-Stimulated Adipose-Derived Mesenchymal Stem Cells on NAFLD Treatment in High-Fat Diet-Fed Rats.脂多糖刺激的脂肪来源间充质干细胞对高脂饮食喂养大鼠非酒精性脂肪性肝病治疗的影响
Iran J Pharm Res. 2023 Jun 24;22(1):e134807. doi: 10.5812/ijpr-134807. eCollection 2023 Jan-Dec.
5
Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity.八周极低卡路里生酮饮食(VLCKD)对超重和肥胖患者代谢功能障碍相关脂肪性肝病(MASLD)的白细胞和血小板计数的影响。
Nutrients. 2023 Oct 21;15(20):4468. doi: 10.3390/nu15204468.
6
Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study.弗雷明汉脂肪肝指数对心血管风险的预测价值:一项基于全国人群的队列研究。
Front Cardiovasc Med. 2023 Jul 18;10:1163052. doi: 10.3389/fcvm.2023.1163052. eCollection 2023.
7
The Effects of Eight Weeks' Very Low-Calorie Ketogenic Diet (VLCKD) on Liver Health in Subjects Affected by Overweight and Obesity.八周极低卡路里生酮饮食(VLCKD)对超重和肥胖人群肝脏健康的影响。
Nutrients. 2023 Feb 6;15(4):825. doi: 10.3390/nu15040825.
8
Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.每周一次皮下注射司美格鲁肽可改善 2 型糖尿病患者的脂肪肝疾病:一项为期 52 周的前瞻性真实世界研究。
Nutrients. 2022 Nov 4;14(21):4673. doi: 10.3390/nu14214673.
糖尿病家族史与生活方式干预对中国代谢综合征人群胰岛素分泌和胰岛素抵抗的影响。
J Diabetes Res. 2021 Jan 4;2021:8822702. doi: 10.1155/2021/8822702. eCollection 2021.
4
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
5
Family history of diabetes in both parents is strongly associated with impaired residual β-cell function in Japanese type 2 diabetes patients.父母双方均有糖尿病家族史与日本 2 型糖尿病患者残余β细胞功能受损密切相关。
J Diabetes Investig. 2020 May;11(3):564-572. doi: 10.1111/jdi.13176. Epub 2019 Dec 13.
6
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
7
Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.糖化血红蛋白与无糖尿病的非酒精性脂肪性肝病患者发生晚期纤维化的风险相关。
Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):58-66. doi: 10.1016/j.clinre.2018.08.007. Epub 2018 Sep 28.
8
Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey.非酒精性脂肪性肝病的危险因素和生物标志物:一项观察性横断面人群调查。
BMJ Open. 2018 Apr 5;8(4):e019974. doi: 10.1136/bmjopen-2017-019974.
9
Association between smoking and non-alcoholic fatty liver disease: A systematic review and meta-analysis.吸烟与非酒精性脂肪性肝病之间的关联:一项系统评价和荟萃分析。
SAGE Open Med. 2018 Jan 24;6:2050312117745223. doi: 10.1177/2050312117745223. eCollection 2018.
10
Effect of parental history of diabetes on markers of inflammation, insulin resistance and atherosclerosis in first degree relatives of patients with type 2 diabetes mellitus.糖尿病家族史对2型糖尿病患者一级亲属炎症、胰岛素抵抗和动脉粥样硬化标志物的影响。
Diabetes Metab Syndr. 2018 May;12(3):285-289. doi: 10.1016/j.dsx.2017.12.004. Epub 2017 Dec 15.